Financial Survey: CochLear (OTCMKTS:CHEOY) & SeaStar Medical (NASDAQ:ICU)

SeaStar Medical (NASDAQ:ICU) and CochLear (OTCMKTS:CHEOY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Volatility and Risk

SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the S&P 500. Comparatively, CochLear has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.

Earnings and Valuation

This table compares SeaStar Medical and CochLear”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.44 million	8.68	-$12.15 million	($4.80)	-0.65
CochLear	$1.53 billion	3.50	$251.85 million	N/A	N/A

CochLear has higher revenue and earnings than SeaStar Medical.

Profitability

This table compares SeaStar Medical and CochLear’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
CochLear	N/A	N/A	N/A

Institutional & Insider Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings for SeaStar Medical and CochLear, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1	0	1	0	2.00
CochLear	0	3	1	1	2.60

SeaStar Medical presently has a consensus target price of $8.00, indicating a potential upside of 156.41%. Given SeaStar Medical’s higher probable upside, equities research analysts plainly believe SeaStar Medical is more favorable than CochLear.

Summary

CochLear beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.